Literature DB >> 15635197

Persistent hyperglycemia is associated with left ventricular dysfunction in patients with acute myocardial infarction.

Masami Kosuge1, Kazuo Kimura, Toshiyuki Ishikawa, Tomoaki Shimizi, Kiyoshi Hibi, Noritaka Toda, Yoshio Tahara, Masahiko Kanna, Kengo Tsukahara, Jyunn Okuda, Naoki Nozawa, Satoshi Umemura.   

Abstract

BACKGROUND: The relationship of changes in blood glucose concentrations after admission to left ventricular (LV) dysfunction in patients with recanalized anterior acute myocardial infarction (AMI) remains unclear. METHODS AND
RESULTS: Blood glucose concentrations were measured on admission and 24 h after symptom onset in 210 patients with recanalized anterior AMI within 6 h of symptom onset. Of them, 142 had hyperglycemia on admission, defined as a blood glucose >or=8.9 mmol/L, and 68 patients did not. Among the patients with admission hyperglycemia, 49 had persistent hyperglycemia, defined as a blood glucose >or=8.9 mmol/L 24 h after onset, and 93 did not. The incidences of myocardial blush grade of 0/1 after recanalization indicating impaired myocardial perfusion (71%), and peak creatine kinase concentration (5,631+/-2,855 mU/ml) were higher and predischarge LV function (43+/-11%) was lower in patients with persistent hyperglycemia than in those without (p<0.01). Multivariate analysis showed that persistent hyperglycemia was independently associated with LV dysfunction, defined as a predischarge LV ejection fraction <or=40% (odds ratio 7.38, p=0.001).
CONCLUSIONS: Persistent hyperglycemia at 24 h after symptom onset is associated with LV dysfunction before discharge in patients with recanalized anterior AMI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635197     DOI: 10.1253/circj.69.23

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction.

Authors:  Joanna Gierach; Marcin Gierach; Iwona Świątkiewicz; Marek Woźnicki; Grzegorz Grześk; Adam Sukiennik; Marek Koziñski; Jacek Kubica
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

Review 2.  How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.

Authors:  Irl B Hirsch; Kevin D O'Brien
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

3.  Short and long-term prognosis of admission hyperglycemia in patients with and without diabetes after acute myocardial infarction: a retrospective cohort study.

Authors:  Hanzohra Upur; Jia-Li Li; Xiao-Guang Zou; Yu-Ying Hu; He-Yin Yang; Alimujiang Abudoureyimu; Anwar Abliz; Mamatili Abdukerim; Min Huang
Journal:  Cardiovasc Diabetol       Date:  2022-06-23       Impact factor: 8.949

4.  Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome.

Authors:  C Weston; L Walker; J Birkhead
Journal:  Heart       Date:  2007-05-13       Impact factor: 5.994

5.  A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group.

Authors:  Kenji Yanishi; Takeshi Nakamura; Naohiko Nakanishi; Isao Yokota; Kan Zen; Tetsuhiro Yamano; Hirokazu Shiraishi; Takeshi Shirayama; Jun Shiraishi; Takahisa Sawada; Yoshio Kohno; Makoto Kitamura; Keizo Furukawa; Satoaki Matoba
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

6.  Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial.

Authors:  Raquel Pei Chen Chan; Filomena Regina Barbosa Gomes Galas; Ludhmila Abrahão Hajjar; Carmen Narvaes Bello; Marilde Albuquerque Piccioni; José Otávio Costa Auler
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

7.  Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group.

Authors:  Amir Shamshirian; Reza Alizadeh-Navaei; Samira Abedi; Hamed Jafarpour; Hanieh Fazli; Samira Hosseini; Amirhossein Hessami; Keyvan Karimifar; Sedighe Yosefi; Mohammad Zahedi; Sepideh Motamen; Atiyeh Ghorbanpour; Bahman Zarandi; Aliakbar Esfahani; Yeganeh Rostamian-Moghaddam; Shirin Mehdipour; Keyvan Heydari; Sedigheh Aghajanian; Somayeh Pour Mehdi; Alireza Azad; Soheil Azizi
Journal:  Ethiop J Health Sci       Date:  2020-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.